Epigenetic biomarkers and preterm birth
Environmental Epigenetics · 01.01.2020 · 6 (1)
DOI: 10.1093/eep/dvaa005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Environmental Epigenetics, online erschienen am 14.06.2020. Verfasst von Bongsoo Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NIEHS, Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Preterm birth (PTB) is a major public health challenge, and novel, sensitive approaches to predict PTB are still evolving. Epigenomic markers are being explored as biomarkers of PTB because of their molecular stability compared to gene expression. This approach is also relatively new compared to gene-based diagnostics, which relies on mutations or single nucleotide polymorphisms. The fundamental principle of epigenome diagnostics is that epigenetic reprogramming in the target tissue (e.g. placental tissue) might be captured by more accessible surrogate tissue (e.g. blood) using biochemical epigenome assays on circulating DNA that incorporate methylation, histone modifications, nucleosome positioning, and/or chromatin accessibility. Epigenomic-based biomarkers may hold great potential for early identification of the majority of PTBs that are not associated with genetic variants or mutations. In this review, we discuss recent advances made in the development of epigenome assays focusing on its potential exploration for association and prediction of PTB. We also summarize population-level cohort studies conducted in the USA and globally that provide opportunities for genetic and epigenetic marker development for PTB. In addition, we summarize publicly available epigenome resources and published PTB studies. We particularly focus on ongoing genome-wide DNA methylation and epigenome-wide association studies. Finally, we review the limitations of current research, the importance of establishing a comprehensive biobank, and possible directions for future studies in identifying effective epigenome biomarkers to enhance health outcomes for pregnant women at risk of PTB and their infants.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
- Department of International Health, Johns Hopkins Bloomberg School of Public Health, International Center for Maternal and Newborn Health, Baltimore, MD 21205, USA.
- School of Medicine, Cardiovascular Research Institute, Case Western Reserve University, Cleveland, OH 44106, USA.
- Department of Health and Human Services, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
ORCID-Profile: Bongsoo Park, Stephanie J London
Förderung
- NIEHS NIH HHS
- NIEHS
- Bill and Melinda Gates Foundation
- World Health Organization
- NIH
- National Institute of Environmental Health Sciences
Zitieren
APA
Park, B., Khanam, R., Vinayachandran, V., Baqui, A. H., London, S. J., & Biswal, S. (2020). Epigenetic biomarkers and preterm birth. Environmental Epigenetics, 6(1). https://doi.org/10.1093/eep/dvaa005
Vancouver
Park B, Khanam R, Vinayachandran V, Baqui AH, London SJ, Biswal S. Epigenetic biomarkers and preterm birth. Environmental Epigenetics. 2020;6(1). doi:10.1093/eep/dvaa005
BibTeX
@article{Park2020,
author = {Park, Bongsoo and Khanam, Rasheda and Vinayachandran, Vinesh and Baqui, Abdullah H and London, Stephanie J and Biswal, Shyam},
title = {Epigenetic biomarkers and preterm birth},
journal = {Environmental Epigenetics},
year = {2020},
volume = {6},
number = {1},
doi = {10.1093/eep/dvaa005}
}
EUVIMED